Cite
Santi MD, Peralta MA, Puiatti M, et al. Melanogenic inhibitory effects of Triangularin in B16F0 melanoma cells, in vitro and molecular docking studies. Bioorg Med Chem. 2019;27(16):3722-3728doi: 10.1016/j.bmc.2019.06.041.
Santi, M. D., Peralta, M. A., Puiatti, M., Cabrera, J. L., & Ortega, M. G. (2019). Melanogenic inhibitory effects of Triangularin in B16F0 melanoma cells, in vitro and molecular docking studies. Bioorganic & medicinal chemistry, 27(16), 3722-3728. https://doi.org/10.1016/j.bmc.2019.06.041
Santi, María D, et al. "Melanogenic inhibitory effects of Triangularin in B16F0 melanoma cells, in vitro and molecular docking studies." Bioorganic & medicinal chemistry vol. 27,16 (2019): 3722-3728. doi: https://doi.org/10.1016/j.bmc.2019.06.041
Santi MD, Peralta MA, Puiatti M, Cabrera JL, Ortega MG. Melanogenic inhibitory effects of Triangularin in B16F0 melanoma cells, in vitro and molecular docking studies. Bioorg Med Chem. 2019 Aug 15;27(16):3722-3728. doi: 10.1016/j.bmc.2019.06.041. Epub 2019 Jun 27. PMID: 31272835.
Copy
Download .nbib